392 related articles for article (PubMed ID: 18702433)
1. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
Charipar R; Charipar E
WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
[TBL] [Abstract][Full Text] [Related]
2. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
4. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
5. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments.
Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC
J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925
[TBL] [Abstract][Full Text] [Related]
6. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
7. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
[TBL] [Abstract][Full Text] [Related]
8. The yield of expanding the therapeutic time window for tPA.
Owe JF; Sanaker PS; Naess H; Thomassen L
Acta Neurol Scand; 2006 Nov; 114(5):354-7. PubMed ID: 17022786
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
[TBL] [Abstract][Full Text] [Related]
10. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
11. Virtual TeleStroke support for the emergency department evaluation of acute stroke.
Schwamm LH; Rosenthal ES; Hirshberg A; Schaefer PW; Little EA; Kvedar JC; Petkovska I; Koroshetz WJ; Levine SR
Acad Emerg Med; 2004 Nov; 11(11):1193-7. PubMed ID: 15528584
[TBL] [Abstract][Full Text] [Related]
12. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
13. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
14. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
16. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
[TBL] [Abstract][Full Text] [Related]
17. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
[TBL] [Abstract][Full Text] [Related]
18. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
Laloux P; Thijs V; Peeters A; Desfontaines P
Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
[TBL] [Abstract][Full Text] [Related]
19. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
Uchino K; Massaro L; Hammer MD
Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
[TBL] [Abstract][Full Text] [Related]
20. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
Dowlatshahi D; Hakim A; Fang J; Sharma M;
Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
